GlassScriptPhysician profile
Albert C Hammett
NPI 1366449209
$6,264.09
in general payments reported to CMS, 2019-2025
32 companies · $501 in 2025
The $501 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,123 · 2020: $297 · 2021: $1,264 · 2022: $1,006 · 2023: $1,367 · 2024: $707 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,574.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $770.27 | 2019-2025 | Eliquis, Opdivo, Camzyos |
| Novartis Pharmaceuticals Corporation | $768.75 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $726.50 | 2019-2023 | Xarelto |
| Amgen INC. | $563.91 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $483.94 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $380.83 | 2019-2025 | Lifevest |
| Esperion Therapeutics, INC. | $378.23 | 2021-2024 | Nexletol, Nexlizet |
| Boehringer Ingelheim Pharmaceuticals, INC. | $361.75 | 2019-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $220.77 | 2021-2025 | Verquvo |
| Bard Peripheral Vascular, INC. | $210.74 | 2020-2021 | |
| Boston Scientific Corporation | $189.08 | 2019-2023 | Bodyguardian |
| Becton, Dickinson and Company | $154.36 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $150.18 | 2019-2024 | Farxiga |
| Abiomed | $140.02 | 2021-2024 | Impella |
| Abbott Laboratories | $114.04 | 2020-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $112.89 | 2021 | |
| Gilead Sciences, INC. | $62.31 | 2019 | |
| Cardiovascular Systems INC. | $58.21 | 2019-2020 | |
| Amarin Pharma, INC. | $57.57 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $49.91 | 2019 | |
| Alnylam Pharmaceuticals INC. | $48.13 | 2022 | |
| Kestra Medical Technology Services, INC. | $40.04 | 2025 | Assure Wcd |
| Lexicon Pharmaceuticals, INC. | $31.75 | 2023 | Inpefa |
| Inari Medical, INC. | $30.72 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kerecis Limited | $28.46 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Bardy Diagnostics, INC. | $24.31 | 2022 | |
| Irhythm Technologies, INC. | $22.06 | 2019 | |
| Itamar Medical INC | $20.58 | 2024 | Watchpatone |
| Novo Nordisk INC | $18.17 | 2024 | Ozempic |
| Kiniksa Pharmaceuticals, LTD. | $16.61 | 2023 | Arcalyst |
| Baxter Healthcare | $14.66 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Medtronic Vascular, INC. | $14.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Hammett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.